TCP-MP-CA

TCP-MP-CA

• UNSPSC Description: TCP-MP-CA (compound 11a) is an inhibitor of LSD1 demethylation enzymatic via binding to LSD1/CoREST complex. TCP-MP-CA exhibits an inhibitory effect on osteoclastogenesis, with an IC50 value of 0.14 µM[1].
• Target Antigen: Histone Demethylase
• Type: Reference compound
• Related Pathways: Epigenetics
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/tcp-mp-ca.html
• Smiles: OC1=C(O)C=C(/C=C/C(N2CCC(CN[C@H]3[C@H](C4=CC=CC=C4)C3)CC2)=O)C=C1.Cl
• Molecular Weight: 428.95
• References & Citations: [1]Zhihao Chen, et al. Discovery of TCP-(MP)-caffeic acid analogs as a new class of agents for treatment of osteoclastic bone loss. Bioorg Chem. 2024 Sep:150:107603.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported